Steven Cohen's TNXP Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.17 M shares of Tonix Pharmaceuticals Holding Corp. (TNXP) worth $14.89 M, representing 0.02% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Steven Cohen has maintained this position in TNXP for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 1.04 M shares. Largest reduction occurred in Q1 2026, reducing 494,619 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Tonix Pharmaceuticals Holding (TNXP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tonix Pharmaceuticals Holding (TNXP) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.04 M | Add 830.32% | 1.17 M | $12.76 |
| Q1 2026 | -494,619 | Reduce 79.77% | 125,414 | $13.75 |
| Q4 2025 | +620,033 | New Buy | 620,033 | $15.62 |
Steven Cohen's Tonix Pharmaceuticals Holding Investment FAQs
Steven Cohen first purchased Tonix Pharmaceuticals Holding Corp. (TNXP) in Q4 2025, acquiring 620,033 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Tonix Pharmaceuticals Holding Corp. (TNXP) for 3 quarters since Q4 2025.
Steven Cohen's largest addition to Tonix Pharmaceuticals Holding Corp. (TNXP) was in Q2 2026, adding 1,166,752 shares worth $14.89 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,166,752 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), valued at approximately $14.89 M.
As of the Q2 2026 filing, Tonix Pharmaceuticals Holding Corp. (TNXP) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Tonix Pharmaceuticals Holding Corp. (TNXP) was 1,166,752 shares, as reported at the end of Q2 2026.